Egg Binding Bird Emergency Treatment

Agent not found.

This is a classic avian emergency, but the specific protocols for drug selection, dosing, and advanced procedures like ovocentesis are squarely in the wheelhouse of an avian specialist. My role would be to provide immediate supportive care—a warm, dark, quiet, oxygen-supplemented environment and ensuring vascular access if possible for fluid support—while urgently getting the avian service involved.

The decision between oxytocin and prostaglandin, the specific technique for ovocentesis, and long-term prevention are highly species- and case-specific. I defer to my avian colleague for the definitive treatment plan here.

Colleague, this is a classic presentation that requires careful, stepwise pharmacological intervention. Let's focus on the drug therapy; I'll defer to the avian specialist on the team for procedural specifics and long-term management.

First, address the hypocalcemia and dehydration, as these are primary drivers of uterine inertia.
* Calcium Gluconate (10% solution): The standard dose is 50-100 mg/kg. For a typical 80g cockatiel, this is 4-8 mg total. This equates to 0.04-0.08 mL of 10% solution. Give this IM or SC, diluted with saline, along with parenteral fluids. IV administration is an option in a critical, catheterized patient but must be done very slowly and diluted to avoid cardiac arrhythmias. The goal is to restore normal myometrial contractility.

Next is the choice of ecbolic agent. This is a critical decision point.
* Oxytocin: I strongly advise against using oxytocin as a first-line agent. Avian shell glands lack significant oxytocin receptors; they primarily have arginine vasotocin (AVT) receptors. Oxytocin may cause premature closure of the uterovaginal sphincter before stimulating effective shell gland contraction, potentially trapping the egg and increasing the risk of uterine rupture. It should only be considered if the egg is already visible at the cloaca and just needs a final push.
* Prostaglandin F2α (Dinoprost) or E2 (Misoprostol): This is the more physiologically sound choice. Prostaglandins relax the uterovaginal sphincter and cervix while stimulating coordinated contractions of the shell gland. A very low dose of PGF2α (0.01-0.02 mg/kg) can be applied topically to the uterovaginal mucosa via a catheter or cotton-tipped swab. Extreme caution is required: wear gloves, as it is readily absorbed transdermally and can affect pregnant staff. It can also cause bronchoconstriction. Have the patient stabilized on oxygen before use.

Finally, do not forget analgesia. Dystocia is painful.
* Butorphanol: 0.5-2.0 mg/kg IM provides effective, reversible analgesia.

In summary: Stabilize with fluids and calcium first. Provide analgesia. Then, if the egg has not passed within an hour or two, consider a low dose of a topical prostaglandin. Re-dose calcium as needed based on clinical response. If medical management fails, I will defer to my colleagues for the discussion on ovocentesis.